1) IV clinical trial
IV期临床试验
1.
Drug registration of IV clinical trials as an important part of the management, and related laws and regulations in the newly revised "Drug Registration Management Measures" and the provisions of the actual work there are still many issues to be studied.
其中,IV期临床试验作为药品注册管理的重要内容,在新修订的《药品注册管理办法》的规定和实际工作中存在诸多值得研究的问题。
3) phase Ⅲ clinical trial
Ⅲ期临床试验
1.
Methods: The phase Ⅲ clinical trial was conducted in 510 patients with chronic bronchitis.
方法:本试验为Ⅲ期临床试验,随机选取510例慢性支气管炎迁延期的患者,从咳嗽、咳痰、喘息、肺部哮鸣音、肺功能、肺部X线征象等方面观察治疗前后的变化,进行统计学处理,并考察其安全性。
4) Phase II clinical trial
II期临床试验
补充资料：Hydrogen hexachloro platinum (IV) hydrate hydrogen hexachloroplatinate(iv) hydrate,reagent acs Hydrogen hexachloro platinum(IV)hydrate
CAS：26023-84-7
分子式：H2Cl6Pt.xH2O
中文名称：六氯氢铂(Ⅳ)水合物
英文名称：Hydrogen hexachloro platinum (IV) hydrate hydrogen hexachloroplatinate(iv) hydrate,reagent acs Hydrogen hexachloro platinum(IV)hydrate
分子式：H2Cl6Pt.xH2O
中文名称：六氯氢铂(Ⅳ)水合物
英文名称：Hydrogen hexachloro platinum (IV) hydrate hydrogen hexachloroplatinate(iv) hydrate,reagent acs Hydrogen hexachloro platinum(IV)hydrate
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条